Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HEROSTEM BIOTECHNOLOGY logo — company profile

HEROSTEM BIOTECHNOLOGY

Founded 2012 Series A Total: $15.00M Biotechnology, Health Care

General Information

Company Name HEROSTEM BIOTECHNOLOGY
Founded Year 2012
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when HEROSTEM BIOTECHNOLOGY moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HEROSTEM BIOTECHNOLOGY

HEROSTEM BIOTECHNOLOGY is a biotechnology startup, founded in 2012, specializing in stem cell research and clinical applications. The company holds fully independent intellectual property rights in stem cell technology and sources stem cells from early adult tissues, making it among the earliest stage stem cells that can be extracted. Its business scope includes services for umbilical cord, placenta, umbilical cord blood stem cell preparation and storage, and more. The startup received a CNY15.00M Series A investment on 21 November 2015 from AEON LIFE, a significant milestone that showcases investor confidence in its potential within the Biotechnology and Health Care industries.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 21 Nov 2015

HEROSTEM BIOTECHNOLOGY Alternatives & Competitors

HEROSTEM BIOTECHNOLOGY vs
Life Line Stem Cell
Life Line Stem Cell United States

We offer expectant parents the opportunity to donate umbilical cords/blood, & placenta for transplan...

39 employees
HEROSTEM BIOTECHNOLOGY vs
Health & Biotech
Health & Biotech

Health & Biotech Co. Ltd (H&B) specializes in placenta-umbilical cord derived stem cells storage, re...

4 employees
Biotechnology, Life Sciences
HEROSTEM BIOTECHNOLOGY vs
Cord Blood America
Cord Blood America United States

Cord Blood America, Inc.(CBAI), through its wholly owned subsidiary CorCell Companies, Inc., is enga...

Post Ipo Equity
11 employees
Biotechnology, Health Care

FAQ About HEROSTEM BIOTECHNOLOGY

HEROSTEM BIOTECHNOLOGY specializes in stem cell research and clinical applications, with fully independent intellectual property rights in stem cell technology. The stem cells are sourced from early adult tissues and are the earliest stage stem cells that can be extracted. Their business scope inclu...
HEROSTEM BIOTECHNOLOGY was founded in 2012.
HEROSTEM BIOTECHNOLOGY operates in the following industries: Biotechnology, Health Care.
HEROSTEM BIOTECHNOLOGY has completed 1 funding round, raising a total of $15.00M. The latest funding stage is Series A.
Top alternatives and competitors to HEROSTEM BIOTECHNOLOGY include Life Line Stem Cell, Health & Biotech, Cord Blood America, CryoHoldco Biotech, Cells4Life Group LLP. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HEROSTEM BIOTECHNOLOGY and Life Line Stem Cell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HEROSTEM BIOTECHNOLOGY and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy